The Star Family Member

QKI and Cell Signaling
  • Yue FengEmail author
  • Andrew Bankston
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 693)


The family of Signal Transduction and Activators of RNA (STAR) is named based on the intriguing potential for these proteins to connect cell signaling directly to the homeostasis of their mRNA ligands. Besides the commonly shared single RNA binding domain that displays heterogeneous nuclear ribonucleoprotein K homology (KH), STAR proteins also harbor domains predicted to bind critical components in signal transduction pathways, in particular the Src-family protein tyrosine kinases (Src-PTK s). Indeed, accumulating evidence in recent years has demonstrated that the RNA-binding activity and the homeostasis of downstream mRNA targets of STAR proteins can be regulated by phosphorylation in response to various extracellular signals. This chapter provides a short review of the STAR member QKI, focusing on the essential role of QKI in development of the central nervous system, possible mechanisms by which QKI may link cell signaling to the cellular behavior of its mRNA targets and how QKI dysregulation may contribute to human diseases.


Myelin Basic Protein Cell Cycle Exit Myelin Development Oligodendrocyte Precursor Cell Migration mRNA Ligand 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Ebersole TA, Chen Q, Justice MJ et al. The quaking gene product necessary in embryogenesis and myelination combines features of RNA binding and signal transduction proteins [see comments]. Nat Genet 1996; 12:260–265.CrossRefPubMedGoogle Scholar
  2. 2.
    Zorn AM, Krieg PA. The KH domain protein encoded by quaking functions as a dimer and is essential for notochord development in Xenopus embryos. Genes Dev 1997; 11:2176–2190.CrossRefPubMedGoogle Scholar
  3. 3.
    Zaffran S, Astier M, Gratecos D et al. The held out wings (how) Drosophila gene encodes a putative RNA-binding protein involved in the control of muscular and cardiac activity. Development 1997; 124:2087–2098.PubMedGoogle Scholar
  4. 4.
    Li ZZ, Kondo T, Murata T et al. Expression of Hqk encoding a KH RNA binding protein is altered in human glioma. Jpn J Cancer Res 2002; 93:167–177.PubMedGoogle Scholar
  5. 5.
    Kondo T, Furuta T, Mitsunaga K et al. Genomic organization and expression analysis of the mouse qkI locus. Mammalian Genome 1999; 10:662–669.CrossRefPubMedGoogle Scholar
  6. 6.
    Vernet C, Artzt K. STAR, a gene family involved in signal transduction and activation of RNA. Trends Genet 1997; 13:479–484.CrossRefPubMedGoogle Scholar
  7. 7.
    Bockbrader K, Feng Y. Essential function, sophisticated regulation and pathological impact of the selective RNA-binding protein QKI in CNS myelin development. Future Neurol 2008; 3:655–668.CrossRefPubMedGoogle Scholar
  8. 8.
    Zhang Y, Lu Z, Ku L et al. Tyrosine-phosphorylation of QKI mediates developmental signals to regulate mRNA metabolism. EMBO J 2003.Google Scholar
  9. 9.
    Wu J, Zhou L, Tonissen K et al. The quaking I-5 protein (QKI-5) has a novel nuclear localization signal and shuttles between the nucleus and the cytoplasm. J Biol Chem 1999; 274:29202–29210.CrossRefPubMedGoogle Scholar
  10. 10.
    Galarneau A, Richard S. Target RNA motif and target mRNAs of the Quaking STAR protein. Nat Struct Mol Biol 2005; 12:691–698.CrossRefPubMedGoogle Scholar
  11. 11.
    Li Z, Takakura N, Oike Y et al. Defective smooth muscle development in qkI-deficient mice. Dev Growth Differ 2003; 45:449–462.CrossRefPubMedGoogle Scholar
  12. 12.
    Hardy RJ. Molecular defects in the dysmyelinating mutant quaking. Journal of Neuroscience Research 1998; 51:417–422.CrossRefPubMedGoogle Scholar
  13. 13.
    Lu Z, Zhang Y, Ku L et al. The quakingviable mutation affects qkI mRNA expression specifically in myelin-producing cells of the nervous system. Nucleic Acids Res 2003; 31:4616–4624.CrossRefPubMedGoogle Scholar
  14. 14.
    Hardy RJ, Loushin CL, Friedrich VL Jr et al. Neural cell type-specific expression of QKI proteins is altered in quakingviable mutant mice. Journal of Neuroscience 1996; 16:7941–7949.PubMedGoogle Scholar
  15. 15.
    Larocque D, Fragoso G, Huang J et al. The QKI-6 and QKI-7 RNA binding proteins block proliferation and promote Schwann cell myelination. PLoS One 2009; 4:e5867.CrossRefPubMedGoogle Scholar
  16. 16.
    Chen Y, Tian D, Ku L et al. The selective RNA-binding protein quaking I (QKI) is necessary and sufficient for promoting oligodendroglia differentiation. J Biol Chem 2007; 282:23553–23560.CrossRefPubMedGoogle Scholar
  17. 17.
    Larocque D, Galarneau A, Liu HN et al. Protection of p27(Kip1) mRNA by quaking RNA binding proteins promotes oligodendrocyte differentiation. Nat Neurosci 2005; 8:27–33.CrossRefPubMedGoogle Scholar
  18. 18.
    Li Z, Zhang Y, Li D et al. Destabilization and mislocalization of myelin basic protein mRNAs in quaking dysmyelination lacking the QKI RNA-binding proteins. J Neurosci 2000; 20:4944–4953.PubMedGoogle Scholar
  19. 19.
    Wu HY, Dawson MR, Reynolds R et al. Expression of QKI proteins and MAP1B identifies actively myelinating oligodendrocytes in adult rat brain. Mol Cell Neurosci 2001; 17:292–302.CrossRefPubMedGoogle Scholar
  20. 20.
    Zhao L, Tian D, Xia M et al. Rescuing qkV dysmyelination by a single isoform of the selective RNA-binding protein QKI. J Neurosci 2006; 26:11278–11286.CrossRefPubMedGoogle Scholar
  21. 21.
    Aberg K, Saetre P, Lindholm E et al. Human QKI, a new candidate gene for schizophrenia involved in myelination. Am J Med Genet B Neuropsychiatr Genet 2006; 141:84–90.Google Scholar
  22. 22.
    Aberg K, Saetre P, Jareborg N et al. Human QKI, a potential regulator of mRNA expression of human oligodendrocyte-related genes involved in schizophrenia. Proc Natl Acad Sci USA 2006; 103:7482–7487.CrossRefPubMedGoogle Scholar
  23. 23.
    Haroutunian V, Katsel P, Dracheva S et al. The human homolog of the QKI gene affected in the severe dysmyelination “quaking” mouse phenotype: downregulated in multiple brain regions in schizophrenia. Am J Psychiatry 2006; 163:1834–1837CrossRefPubMedGoogle Scholar
  24. 24.
    Klempan TA, Ernst C, Deleva V et al. Characterization of QKI Gene Expression, Genetics and Epigenetics in Suicide Victims with Major Depressive Disorder. Biol Psychiatry 2009.Google Scholar
  25. 25.
    Yin D, Ogawa S, Kawamata N et al. High-resolution genomic copy number profiling of glioblastoma multiforme by single nucleotide polymorphism DNA microarray. Mol Cancer Res 2009; 7:665–677.CrossRefPubMedGoogle Scholar
  26. 26.
    Mulholland PJ, Fiegler H, Mazzanti C et al. Genomic profiling identifies discrete deletions associated with translocations in glioblastoma multiforme. Cell Cycle 2006; 5:783–791.CrossRefPubMedGoogle Scholar
  27. 27.
    Ichimura K, Mungall AJ, Fiegler H et al. Small regions of overlapping deletions on 6q26 in human astrocytic tumours identified using chromosome 6 tile path array-CGH. Oncogene 2006; 25:1261–1271.CrossRefPubMedGoogle Scholar
  28. 28.
    Yang G, Fu H, Zhang J et al. RNA binding protein Quaking, a critical regulator of colon epithelial differentiation and a suppressor of colon cancer. Gastroenterology 2009.Google Scholar
  29. 29.
    McInnes LA, Lauriat TL. RNA metabolism and dysmyelination in schizophrenia. Neurosci Biobehav Rev 2006; 30:551–561.CrossRefPubMedGoogle Scholar
  30. 30.
    Hardy RJ. QKI expression is regulated during neuron-glial cell fate decisions. J Neurosci Res 1998; 54:46–57.CrossRefPubMedGoogle Scholar
  31. 31.
    Wang E, Dimova N, Cambi F. PLP/DM20 ratio is regulated by hnRNPH and F and a novel G-rich enhancer in oligodendrocytes. Nucleic Acids Res 2007; 35:4164–4178.CrossRefPubMedGoogle Scholar
  32. 32.
    Sidman S, Dickie M, Appel S. Mutant Mice (Quaking and Jimpy) with Deficient Myelination in the Central Nervous System. Science 1964; 144:309–311.CrossRefPubMedGoogle Scholar
  33. 33.
    Campagnoni AT, Macklin WB. Cellular and molecular aspects of myelin protein gene expression. Mol Neurobiol 1988; 2:41–89.CrossRefPubMedGoogle Scholar
  34. 34.
    Readhead C, Popko B, Takahashi N et al. Expression of a myelin basic protein gene in transgenic shiverer mice: correction of the dysmyelinating phenotype. Cell 1987; 48:703–712.CrossRefPubMedGoogle Scholar
  35. 35.
    Paronetto MP, Achsel T, Massiello A et al. The RNA-binding protein Sam68 modulates the alternative splicing of Bcl-x. J Cell Biol 2007; 176:929–939.CrossRefPubMedGoogle Scholar
  36. 36.
    Zhao L, Ku L, Chen Y et al. QKI binds MAP1B mRNA and enhances MAP1B expression during oligodendrocyte development. Mol Biol Cell 2006; 17:4179–4186.CrossRefPubMedGoogle Scholar
  37. 37.
    Larocque D, Pilotte J, Chen T et al. Nuclear retention of MBP mRNAs in the quaking viable mice. Neuron 2002; 36:815–829.CrossRefPubMedGoogle Scholar
  38. 38.
    Umemori H, Sata S, Yagi T et al. Initial events of myelination involve Fyn tyrosine kinase signalling. Nature 1994; 367:572–576.CrossRefPubMedGoogle Scholar
  39. 39.
    Osterhout DJ, Wolven A, Wolf RM et al. Morphological differentiation of oligodendrocytes requires activation of Fyn tyrosine kinase. J Cell Biol 1999; 145:1209–1218.CrossRefPubMedGoogle Scholar
  40. 40.
    Lu Z, Ku L, Chen Y et al. Developmental abnormalities of myelin basic protein expression in fyn knock-out brain reveal a role of Fyn in post-transcriptional regulation. J Biol Chem 2005; 280:389–395.PubMedGoogle Scholar
  41. 41.
    Colognato H, Ramachandrappa S, Olsen IM et al. Integrins direct Src family kinases to regulate distinct phases of oligodendrocyte development. J Cell Biol 2004; 167:365–375.CrossRefPubMedGoogle Scholar
  42. 42.
    Saccomanno L, Loushin C, Jan E et al. The STAR protein QKI-6 is a translational repressor. Proc Natl Acad Sci USA 1999; 96:12605–12610.CrossRefPubMedGoogle Scholar
  43. 43.
    Lakiza O, Frater L, Yoo Y et al. STAR proteins quaking-6 and GLD-1 regulate translation of the homologues GLI1 and tra-1 through a conserved RNA 3-UTR-based mechanism. Dev Biol 2005; 287:98–110.CrossRefPubMedGoogle Scholar
  44. 44.
    Wu JI, Reed RB, Grabowski PJ et al. Function of quaking in myelination: regulation of alternative splicing. Proc Natl Acad Sci USA 2002; 99:4233–4238.CrossRefPubMedGoogle Scholar
  45. 45.
    Frame MC. Src in cancer: deregulation and consequences for cell behaviour. Biochim Biophys Acta 2002; 1602:114–130.PubMedGoogle Scholar
  46. 46.
    Wheeler DL, Iida M, Dunn EF. The role of Src in solid tumors. Oncologist 2009; 14:667–678.CrossRefPubMedGoogle Scholar
  47. 47.
    Kalia LV, Gingrich JR, Salter MW. Src in synaptic transmission and plasticity. Oncogene 2004; 23:8007–8016.CrossRefPubMedGoogle Scholar
  48. 48.
    Laursen LS, Chan CW, ffrench-Constant C. An integrin-contactin complex regulates CNS myelination by differential Fyn phosphorylation. J Neurosci 2009; 29:9174–9185.CrossRefPubMedGoogle Scholar
  49. 49.
    Cui QL, Zheng WH, Quirion R et al. Inhibition of Src-like kinases reveals Akt-dependent and-independent pathways in insulin-like growth factor I-mediated oligodendrocyte progenitor survival. J Biol Chem 2005; 280:8918–8928.CrossRefPubMedGoogle Scholar
  50. 50.
    Miyamoto Y, Yamauchi J, Tanoue A. Cdk5 phosphorylation of WAVE2 regulates oligodendrocyte precursor cell migration through nonreceptor tyrosine kinase Fyn. J Neurosci 2008; 28:8326–8337.CrossRefPubMedGoogle Scholar
  51. 51.
    Jarjour AA, Kennedy TE. Oligodendrocyte precursors on the move: mechanisms directing migration. Neuroscientist 2004; 10:99–105.CrossRefPubMedGoogle Scholar
  52. 52.
    Hahn CM, Kleinholz H, Koester MP et al. Role of cyclin-dependent kinase 5 and its activator P35 in local axon and growth cone stabilization. Neuroscience 2005; 134:449–465.CrossRefPubMedGoogle Scholar
  53. 53.
    Gonzalez-Billault C, Del Rio JA, Urena JM et al. A role of MAP1B in Reelin-dependent neuronal migration. Cereb Cortex 2005; 15:1134–1145.CrossRefPubMedGoogle Scholar
  54. 54.
    Rajasekharan S, Baker KA, Horn KE et al. Netrin 1 and Dcc regulate oligodendrocyte process branching and membrane extension via Fyn and RhoA. Development 2009; 136:415–426.CrossRefPubMedGoogle Scholar
  55. 55.
    McKerracher L, Winton MJ. Nogo on the go. Neuron 2002; 36:345–348.CrossRefPubMedGoogle Scholar
  56. 56.
    Marta CB, Taylor CM, Cheng S et al. Myelin associated glycoprotein cross-linking triggers its partitioning into lipid rafts, specific signaling events and cytoskeletal rearrangements in oligodendrocytes. Neuron Glia Biol 2004; 1:35–46.CrossRefPubMedGoogle Scholar
  57. 57.
    Biffiger K, Bartsch S, Montag D et al. Severe hypomyelination of the murine CNS in the absence of myelin-associated glycoprotein and fyn tyrosine kinase. J Neurosci 2000; 20:7430–7437.PubMedGoogle Scholar
  58. 58.
    Seiwa C, Yamamoto M, Tanaka K et al. Restoration of FcRgamma/Fyn signaling repairs central nervous system demyelination. J Neurosci Res 2007; 85:954–966.CrossRefPubMedGoogle Scholar
  59. 59.
    Nakahara J, Tan-Takeuchi K, Seiwa C et al. Signaling via immunoglobulin Fc receptors induces oligodendrocyte precursor cell differentiation. Dev Cell 2003; 4:841–852.CrossRefPubMedGoogle Scholar
  60. 60.
    Kirla RM, Haapasalo HK, Kalimo H et al. Low expression of p27 indicates a poor prognosis in patients with high-grade astrocytomas. Cancer 2003; 97:644–648.CrossRefPubMedGoogle Scholar
  61. 61.
    Zagzag D, Blanco C, Friedlander DR et al. Expression of p27KIP1 in human gliomas: relationship between tumor grade, proliferation index and patient survival. Hum Pathol 2003; 34:48–53.CrossRefPubMedGoogle Scholar
  62. 62.
    de Groot J, Milano V. Improving the prognosis for patients with glioblastoma: the rationale for targeting Src. J Neurooncol 2009.Google Scholar
  63. 63.
    Leroy C, Fialin C, Sirvent A et al. Quantitative phosphoproteomics reveals a cluster of tyrosine kinases that mediates SRC invasive activity in advanced colon carcinoma cells. Cancer Res 2009; 69:2279–2286.CrossRefPubMedGoogle Scholar
  64. 64.
    Hattori K, Fukuzako H, Hashiguchi T et al. Decreased expression of Fyn protein and disbalanced alternative splicing patterns in platelets from patients with schizophrenia. Psychiatry Res 2009; 168:119–128.CrossRefPubMedGoogle Scholar
  65. 65.
    Rybakowski JK, Borkowska A, Skibinska M et al. Polymorphisms of the Fyn kinase gene and a performance on the Wisconsin Card Sorting Test in schizophrenia. Psychiatr Genet 2007; 17:201–204.CrossRefPubMedGoogle Scholar
  66. 66.
    Paronetto MP, Zalfa F, Botti F et al. The nuclear RNA-binding protein Sam68 translocates to the cytoplasm and associates with the polysomes in mouse spermatocytes. Mol Biol Cell 2006; 17:14–24.CrossRefPubMedGoogle Scholar
  67. 67.
    Resnick RJ, Taylor SJ, Lin Q et al. Phosphorylation of the Src substrate Sam68 by Cdc2 during mitosis. Oncogene 1997; 15:1247–1253.CrossRefPubMedGoogle Scholar

Copyright information

© Landes Bioscience and Springer Science+Business Media 2010

Authors and Affiliations

  1. 1.Emory UniversityAtlantaUSA

Personalised recommendations